4//SEC Filing
SALIX PHARMACEUTICALS LTD 4
Accession 0001140361-15-004133
CIK 0001009356operating
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:06 PM ET
Size
9.3 KB
Accession
0001140361-15-004133
Insider Transaction Report
Form 4
D ALONZO THOMAS
Director
Transactions
- Award
Common Stock
2015-02-02+14,662→ 95,587 total
Holdings
- 1,080(indirect: By Trust)
Common Stock
- 6,500(indirect: By Spouse)
Common Stock
- 15,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (15,000 underlying) - 10,450(indirect: By Trust)
Common Stock
- 260(indirect: By LP)
Common Stock
Footnotes (4)
- [F1]Represents a restricted stock award of which one-half will vest on each of the six-month anniversary and the twelve-month anniversary of the grant date, subject to Mr. D'Alonzo's continued employment as Acting Chief Executive Officer of the Issuer.
- [F2]The shares are held by the Thomas W. D'Alonzo Rev Trust U/A DTD 10/24/2001 for which the Reporting Person serves as co-trustee.
- [F3]The shares are held by the Rachel L. D'Alonzo Rev Trust U/A DTD 10/24/2001 for which the Reporting Person serves as co-trustee.
- [F4]Options are 100% vested.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001009356
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 5:06 PM ET
- Size
- 9.3 KB